98%
921
2 minutes
20
Background: Spontaneous echo contrast (SEC) is known to be a predisposition to thromboembolism and cerebrovascular accident. The aim of this study was to investigate the risk factors and the consequences of SEC in patients who were placed on venoarterial extracorporeal membrane oxygenation (VA-ECMO) because of cardiogenic shock.
Methods: Between January 2011 and December 2014, 98 patients underwent the insertion of VA-ECMO because of cardiogenic shock in our institution. Transthoracic and transesophageal echocardiography was performed and interpreted by National Board of Echocardiography certified cardiologists. Patients were divided into 2 groups based on the presence or absence of SEC. Clinical data, echocardiographic measurements, and outcomes were compared between the 2 groups.
Results: Of the 98 patients, 22 patients (22%) had SEC on echocardiography. Patients in the SEC group had a lower ejection fraction (8.0% versus 29%; p < 0.001), a lower pulsatility index (defined by [systolic blood pressure - diastolic blood pressure]/mean blood pressure) while receiving ECMO (0.13 ± 0.14 versus 0.26 ± 0.22; p = 0.009). The SEC group had a higher rate of intracardiac thrombus (46% versus 13%; p = 0.002) and stroke (36% versus 7.9%; p = 0.002). On univariate analysis, intracardiac thrombus, SEC, and low pulsatility were significant risk factors for the development of stroke. On multivariate analysis, SEC was the only independent risk factor for stroke.
Conclusions: SEC on VA-ECMO resulted in an increased risk of intracardiac thrombus and stroke. Maintaining pulsatility while the patient is on ECMO may result in a decreased chance of developing SEC and stroke.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.athoracsur.2016.07.019 | DOI Listing |
A A Pract
September 2025
From the Department of Anesthesiology, Northwestern Medicine, Feinberg School of Medicine, Chicago, Illinois.
Bleeding is common after cardiac surgery and is associated with increased morbidity and mortality. The etiology of coagulopathy after cardiopulmonary bypass is complex, involving systemic inflammation, hemodilution, residual heparin effect, platelet activation, hypothermia, and hyperfibrinolysis. Antifibrinolytic agents such as aprotinin and lysine analogs are used to mitigate hyperfibrinolysis.
View Article and Find Full Text PDFCureus
July 2025
Anesthesiology and Center for Outcomes Research, University of Texas Health Science Center, Houston, USA.
Heparin-induced thrombocytopenia (HIT) is a rare but serious immune-mediated complication of heparin therapy, often resulting in thrombotic events despite adequate anticoagulation. Rapid-onset HIT is a particularly severe variant that occurs within 24 hours of re-exposure to heparin in sensitized individuals with circulating anti-platelet factor 4 (PF4)/heparin antibodies. Although rare, its potential for rapid progression and fatal outcomes necessitates a high index of clinical suspicion, especially in perioperative settings involving routine heparin use.
View Article and Find Full Text PDFEur Heart J Qual Care Clin Outcomes
August 2025
Centennial Heart at Parkridge, Parkridge Medical Center, Chattanooga, TN, USA.
Background: Racial disparities in outcomes for patients requiring temporary mechanical circulatory support (tMCS) after acute myocardial infarction (AMI) remain unclear.
Objective: To evaluate racial disparities in patients requiring tMCS following AMI.
Methods: Using the TriNetX US collaborative network (2009-2023), we identified non-Hispanic Black (NHB) and non-Hispanic White (NHW) adults who had AMI and required tMCS.
Int J Surg
August 2025
Department of Liver Transplantation, Cleveland Clinic, Abu Dhabi, United Arab Emirates.
Background: Intracardiac thrombosis (ICT) during liver transplantation (LT) is a rare but life-threatening complication with limited data regarding its risk factors, management, and outcomes. This study aimed to identify factors associated with ICT development, define predictors of intraoperative outcomes and propose a novel classification and management algorithm for ICT.
Methods: A multicenter, international retrospective case-control study was conducted on liver transplant recipients from seven centers between January 2005 and December 2023.
Front Cardiovasc Med
August 2025
Neonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, Rome, Italy.
Background: Neonatal intracardiac thrombosis (ICT) is an uncommon but increasingly recognized condition that impacts neonatal morbidity and mortality, especially in critically ill term and preterm infants. Management includes supportive care and pharmacological or surgical intervention. This study explores the challenges associated with ICT in neonates.
View Article and Find Full Text PDF